These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7853459)

  • 1. Disposition of human drug preparations in the horse. III. Orally administered alclofenac.
    Delbeke FT; Landuyt J; Debackere M
    J Vet Pharmacol Ther; 1994 Oct; 17(5):353-8. PubMed ID: 7853459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of alclofenac in equine plasma and urine by high-performance liquid chromatography.
    Delbeke FT; Landuyt J; Debackere M
    J Chromatogr; 1993 Nov; 621(2):209-14. PubMed ID: 7905004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of human drug preparations in the horse. IV. Orally administered fenoprofen.
    Delbeke FT; Landuyt J; Debackere M
    J Pharm Biomed Anal; 1995 Jul; 13(8):1041-7. PubMed ID: 8580149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of a urinary epoxide metabolite of alclofenac in man.
    Slack JA; Ford-Hutchinson AW
    Drug Metab Dispos; 1980; 8(2):84-6. PubMed ID: 6103793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
    Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of human drug preparations in the horse. I. Rectally administered indomethacin.
    Delbeke FT; Debackere M; Vynckier L
    J Vet Pharmacol Ther; 1991 Jun; 14(2):145-9. PubMed ID: 1920602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses.
    Landoni MF; Lees P
    J Vet Pharmacol Ther; 1995 Dec; 18(6):446-50. PubMed ID: 8789698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
    Pellegrini-Masini A; Poppenga RH; Sweeney RW
    J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of human drug preparations in the horse. VI. Tiaprofenic acid.
    Delbeke FT; Baert K; De Backer P
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):207-14. PubMed ID: 9518152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of fenclofenac in the horse.
    Marsh MV; Caldwell J; Sloan TP; Smith RL; Horner M; Moss MS
    Xenobiotica; 1983 Apr; 13(4):233-40. PubMed ID: 6624138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of ketoprofen in horses after rectal administration.
    Corveleyn S; Deprez P; Van der Weken G; Baeyens W; Remon JP
    J Vet Pharmacol Ther; 1996 Oct; 19(5):359-63. PubMed ID: 8905569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tolfenamic acid in the horse.
    Jaussaud P; Guieu D; Bellon C; Barbier B; Lhopital MC; Sechet R; Courtot D; Toutain PL
    Equine Vet J Suppl; 1992 Feb; (11):69-72. PubMed ID: 9109966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
    Soma LR; Uboh CE; Rudy JA; Smith MS
    Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
    King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
    Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of meloxicam in plasma and urine of horses.
    Toutain PL; Reymond N; Laroute V; Garcia P; Popot MA; Bonnaire Y; Hirsch A; Narbe R
    Am J Vet Res; 2004 Nov; 65(11):1542-7. PubMed ID: 15566093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
    Cox S; Villarino N; Sommardahl C; Kvaternick V; Zarabadipour C; Siger L; Yarbrough J; Amicucci A; Reed K; Breeding D; Doherty T
    Vet J; 2013 Nov; 198(2):382-5. PubMed ID: 24076125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.